TWA
NERV icon

TCI Wealth Advisors’s Minerva Neurosciences NERV Stock Holding History

TCI Wealth Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13
Closed – – 1609
2020
Q3 		$0 Hold
13
– – ﹤0.01% 1609
2020
Q2 		$0 Sell
13
-100
-88% -$5.87K ﹤0.01% 1605
2020
Q1 		$5K Sell
113
-15
-12% -$905 ﹤0.01% 719
2019
Q4 		$7K Buy
128
+53
+71% +$2.34K ﹤0.01% 780
2019
Q3 		$5K Hold
75
– – ﹤0.01% 816
2019
Q2 		$3K Buy
+75
New +$3.75K ﹤0.01% 910

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCI Wealth Advisors's NERV Position: Q4 2020 in Review

TCI Wealth Advisors sold out of Minerva Neurosciences (NERV) in Q4 2020, closing a stake of 13 shares.

TCI Wealth Advisors first reported a position in NERV in Q2 2019 and held it in 6 quarters. The position peaked at $7K in Q4 2019. 76 funds tracked by Wall St. Rank hold NERV as of Q4 2020.

  • TCI Wealth Advisors reported no remaining Minerva Neurosciences position as of Q4 2020 after selling out during the quarter.
  • TCI Wealth Advisors sold 13 Minerva Neurosciences shares in Q4 2020.
  • TCI Wealth Advisors first reported a position in Minerva Neurosciences in Q2 2019 and held it in 6 quarters.
  • TCI Wealth Advisors's Minerva Neurosciences position peaked at $7K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2020.

Based on TCI Wealth Advisors's 13F filing for Q4 2020, filed 21 Jan 2021.